Wealth Enhancement Advisory Services, LLC Bristol Myers Squibb CO Transaction History
Wealth Enhancement Advisory Services, LLC
- $65.4 Billion
- Q4 2025
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 1,533,355 shares of BMY stock, worth $71.8 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
1,533,355
Previous 1,214,457
26.26%
Holding current value
$71.8 Million
Previous $54.8 Million
31.05%
% of portfolio
0.11%
Previous 0.09%
Shares
20 transactions
Others Institutions Holding BMY
# of Institutions
2,724Shares Held
1.58BCall Options Held
28MPut Options Held
28.4M-
Vanguard Group Inc Valley Forge, PA196MShares$9.17 Billion0.14% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.43 Billion0.15% of portfolio
-
State Street Corp Boston, MA96.6MShares$4.52 Billion0.16% of portfolio
-
Jpmorgan Chase & CO New York, NY86.2MShares$4.03 Billion0.26% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA73MShares$3.42 Billion0.55% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $99.5B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...